Stratec stock falls 1.32 percent as the yearly high stays distant

Published on 09/23/2026 at 18:49 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Stratec stock posted a Q2 2026 revenue gain of 2.4 percent on a currency-adjusted basis. The 11.9 percent EBIT margin contrasts with a 12 to 22 percent H2 growth requirement.

Techniker montieren automatisiertes Diagnostik-Analysegerät in modernem Reinraum — Stratec SE (DE000STRA555) fertigt automatisierte Analysesysteme, hier ein Reinraum mit Laborrobotik im Einsatz, Illustration mit AI erstellt.

Stratec stock (ISIN DE000STRA555) stood at EUR 22.50 on Xetra on September 23, 2026, down 1.32 percent from the prior close of EUR 22.80. The market is weighing a Q2 recovery against a demanding second-half growth requirement.

Q2 recovery meets H2 hurdle

According to Ariva on September 17, 2026, Stratec delivered 2.4 percent currency-adjusted revenue growth in Q2 2026 and an EBIT margin of 11.9 percent. The same assessment put the required second-half revenue growth at 12 percent to 22 percent for the company to reach its full-year objectives.

That comparison is the central operating test. Q2 showed an improvement in demand and profitability, but the required H2 range is materially higher than the Q2 revenue increase, leaving the second half responsible for the larger part of the annual recovery.

Yearly range sets the frame

Stratec develops automated instrumentation and consumables for in-vitro diagnostics and life sciences. Its reported Q2 revenue was EUR 59.11 million and net income was EUR 4.162 million for the quarter ended June 30, 2026, giving the operating recovery a concrete earnings base.

At EUR 22.50 on September 23, 2026, the stock was 32.02 percent below its 52-week high of EUR 33.10 and 38.04 percent above its 52-week low of EUR 16.30. The EUR 273,508,695 market capitalization places the valuation question alongside the execution question.

Stratec stock remains below EUR 23

Stratec stock was trading at EUR 22.50 on Xetra on September 23, 2026, with a daily change of minus 1.32 percent. The next market test is whether the second-half revenue acceleration can close the gap between Q2 performance and the 12 percent to 22 percent requirement.